Antares Vision Group, a leader in the digitalization and traceability of products and supply chains for companies and ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the AAW Automated ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Kane will advance strategic priorities and advance Solrikitug, its lead asset, in Phase II trials and prepare for Phase III.

Boehringer Ingelheim and LEO Pharma have signed an exclusive global license and transfer agreement to commercialize and ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

Cellular Origins, the Cell and Gene Therapy Catapult, and Resolution Therapeutics have formed a consortium funded by Innovate ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

The Flamma Group, a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late-stage ...

Grand River Aseptic Manufacturing’s Tyler BeVier on strategic partnerships, cutting-edge capacity, and a patient-first ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

The Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer is ...